COLORECTAL CANCER METASTATIC

This study was designed to test a new two-drug combination for people with advanced colorectal cancer that had stopped responding to standard chemotherapy. The goal was to see if adding an experimental drug (LY3200882) to an existing chemotherapy pill (capecitabine) could help co…

This study is testing whether combining three existing cancer drugs is safe and effective for people with advanced colorectal cancer that has spread. The trial is for patients who cannot receive more intensive chemotherapy. Researchers will first find the safest dose, then see ho…

This study aims to find out if using heat to destroy liver tumors (ablation) works as well as surgically removing them for patients whose colorectal cancer has spread. It will randomly assign 230 eligible patients to receive one of these two treatments. The main goal is to see wh…

This study is for people with colorectal cancer that has spread only to the liver and is considered high-risk. It compares standard chemotherapy alone to chemotherapy plus a targeted liver procedure. The goal is to see if the combined approach is better at shrinking tumors and co…

This early-stage trial is testing the safety and finding the right dose of a two-drug combination (naptumomab estafenatox and durvalumab) for people with advanced or metastatic solid tumors. It will enroll about 120 adults with one of many eligible cancer types, including breast,…

This study is testing a new blood test to see if it can spot the return of cancer better than current standard tests. It involves 55 adults with specific abdominal cancers who are having surgery. Researchers will take blood samples before and after surgery for one year to compare…